Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 226-901-0 | CAS number: 5538-94-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
There are no studies available for the assessment of in vitro genotoxicity of the substance. However, there are three reliable in vitro studies available for a structurally similar substance. The substance (at concentrations up to 50 µg/plate) was found to be negative for mutagenicity in the reverse mutation assay (Ames) employing Salmonella typhimurium strains TA1535, TA1537, TA98, TA102 and TA100 in the presence and absence of a metabolic activation system. The substance was found to be negative for clastogenicity in a chromosome aberration test using Chinese hamster ovary cells in the presence and absence of a metabolic activation system. The substance was found to be negative in the forward mutation assay in CHO cells at the HGPRT locus in the presence and absence of a metabolic activation system.
Link to relevant study records
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 26 August 1986 - 18 Spetember 1986
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
- Remarks:
- Read-across
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- not specified
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian cell transformation assay
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Details on mammalian cell type (if applicable):
- CHO-K1B4
- Metabolic activation:
- with and without
- Metabolic activation system:
- Liver S9 from Aroclor 1254 induced rats.
- Test concentrations with justification for top dose:
- The concentration of the test substance employed was based on the results from a toxicity test. The levels selected were 2, 4, 8 and 16 µg/ml (with S9 mix) and 1, 2, 4 and 8 µg/ml (without S9 mix).
- Vehicle / solvent:
- Distilled water.
- Untreated negative controls:
- yes
- Remarks:
- Vehicle control - distilled water
- Negative solvent / vehicle controls:
- no
- True negative controls:
- yes
- Remarks:
- Untreated control cultuure
- Positive controls:
- yes
- Positive control substance:
- 2-acetylaminofluorene
- cyclophosphamide
- methylmethanesulfonate
- Details on test system and experimental conditions:
- Mitotic inhibitor was colcemid (N-deacetyl-N-methylcolchicine)
- Evaluation criteria:
- All structural chromosome aberrations were assigned artifical lesion or break scores and the aberrations yield quantified as follows:
i) Chromatid and chromosome (isochromatid) gaps, breaks and acentric fragments were counted as one lesion each, indicating that a single event had generated the damage.
ii) Chromatid and chromosome complexes, such as exchanges, rings and dicentrics were designated 2 lesions each, indicating that 2 separate breaks has occurred. A cell containing a rearrangement and an associated fragment was, however, scored as having 2 and not 3 lesions, due to the likely shared origin of this damage.
iii) Metaphase with chromosomes showing multiple and extensive aberrations were awarded an arbitary value of 10 lesions per cell. - Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Conclusions:
- The substance was found to be negative for clastogencity in a chromosome aberration test using Chinese hamster ovary cells in the presence and absence of a metabolic activation system.
- Executive summary:
The substance was tested for clastogenic potential using Chinese hamster ovary cells in vitro in the presence and absence of a metabolic activation system (liver S9 from Aroclor 1254 induced rats). There was no evidence of chromosomal aberrations and no indication of chromosomal ploidy changes following exposure to the substance at concentrations of 2, 4, 8 and 16 µg/ml (with S9 mix) and 1, 2, 4 and 8 µg/ml (without S9 mix). It was concluded that the substance was negative for clastogencity in a chromosome aberration test using Chinese hamster ovary cells in the presence and absence of a metabolic activation system.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 20 March 2001 - 22 March 2001
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- not specified
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Metabolic activation:
- with and without
- Metabolic activation system:
- 10% liver S9 in standard co-factors.
- Test concentrations with justification for top dose:
- Doses were selected based on a range finder study.
using 0.05 to 15 µg/plate without S9.
Dose range finder using 0.15 to 50 µg/plate with S9. - Vehicle / solvent:
- Dimethyl sulphoxide.
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Vehicle
- Positive controls:
- yes
- Positive control substance:
- 2-acetylaminofluorene
- 4-nitroquinoline-N-oxide
- 9-aminoacridine
- N-ethyl-N-nitro-N-nitrosoguanidine
- benzo(a)pyrene
- other: 1,8-Dihydroxyanthraquinone
- Evaluation criteria:
- The test material should have induced a reproducible, dose-related and statistically (Dunnett's method of linear regression) significant increase in the revertant count in at least one strain of bacteria.
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Conclusions:
- The substance (at concentrations up to 50 µg/plate) was found to be negative for mutagenicity in the reverse mutation assay employing Salmonella typhimurium strains TA1535, TA1537, TA98, TA102 and TA100 in the presence and absence of a metabolic activation system.
- Executive summary:
In the in vitro genotoxicity study (Ames test) the substance was tested for mutagenicity in Salmonella typhimurium strains TA1535, TA1537, TA98, TA102 and TA100. Concentrations of up to 50 μg/plate were tested. No evidence of mutagenic activity was seen at any concentration of the substance in the presence and absence of a metabolic activation system. It was concluded that the substance showed no evidence of mutagenic activity in this bacterial system under the test conditions employed.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 14 December 1987 - 18 August 1988
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- 1984
- Deviations:
- yes
- Remarks:
- The recommended performance of an independent repeat experiment for the confirmation of results was not included. The author stated that this deviation did not affect the quality/integrity of the study or the intepretation of the results in this report.
- Qualifier:
- according to guideline
- Guideline:
- EPA OTS 798.5300 (Detection of Gene Mutations in Somatic Cells in Culture)
- Version / remarks:
- 1986
- Deviations:
- yes
- Remarks:
- The recommended performance of an independent repeat experiment for the confirmation of results was not included. The author stated that this deviation did not affect the quality/integrity of the study or the intepretation of the results in this report.
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian cell transformation assay
- Specific details on test material used for the study:
- Substance was stored at room temperature in the dark.
Lot number: B-1889.
Solubility was obtained in sterile deionised water at 50 mg/ml.
Analysis of selected primary stocks were performed within 24 hours of preparation. - Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Details on mammalian cell type (if applicable):
- Hypodiploid CHO-K1-BH4 cell line
- Metabolic activation:
- with and without
- Metabolic activation system:
- Rat liver S9 from animals treated with Aroclor 1254.
- Test concentrations with justification for top dose:
- The concentrations employed in the mutation assay was based on the findings from the rangefinder assay.
Absence of S9: 1 µg/mL to 13 µg/mL
Presence of S9: 1 µg/mL to 40 µg/mL - Vehicle / solvent:
- Deionised water (sterile).
- Untreated negative controls:
- yes
- Remarks:
- Media alone. For the assays in the presence of S9 the media was mixed with the S9 mix.
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Cells were exposed to culture media containing water and no substance.
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 3-methylcholanthrene
- other: 5-Bromo-2-deoxyuridine
- Evaluation criteria:
- The 95% confidence interval must be met as one criterion for considering the substance to be active at a particular dose level. The mutant frequency must meet or exceed 15 x 10-6 in order to compensate for random fluctuations in the 0 to 10 x 10-6 background mutant frequencies that are typical for this assay.
A dose-related or toxicity-related increase in mutant frequency should be observed.
If an increase in mutant frequency is observed for a single dose near the highest testable toxicity and the number of mutant colonies is more than twice the value needed to indicate a significant response, the substance generally will be considered to be mutagenic. Smaller increases at a single dose near the highest testable toxicity will require confirmation by a repeat assay.
Applied concentration or toxicity (percent survival) can be used to establish whether the mutagenic activity is related to an increase in effective treatment.
A substance is evaluated as nonmutagenic in a single assay only if the minimum incrase in mutant frequency is not observable for a range of applied concentrations that extends to concentrations causing about 10% to 15% survival or extends to a concentrations will normally be 5 mg/ml for water soluble materials. If a repeat assay does not cofirm aan earlier, minimal response the substance is evaluated as nonmutagenic in this assay system. - Statistics:
- The statistical tables provided by Kastenbaum and Bowman (1970) are used to determine whether the results at each dose level are significantly different from the vehicle controls at 95% or 99% confidence intervals. This test compares variables distributed according to Poissonian expectations by summing up the probabilities in the tails of two binomial distributions.The 95% confidence interval must be met as one criterion for considering the substance to be actived at a particular dose level.
- Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Conclusions:
- The substance was found to be negative in the forward mutation assay in CHO cells at the HGPRT locus in the presence and absence of a metabolic activation system.
- Executive summary:
The substance was evaluated for its potential to induce forward mutations at the HGPRT locus in the CHO-K1 -BH4 CHO cell line as assessed by colony growth in the presence of 6 -thioguanidine (TG), in the presence and absence of a metabolic activation system (S9). The substance was found to be negative in the assay in the presence and absence of a metabolic activation system.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Description of key information
There are no studies available for the assessment of in vivo genotoxicity of the substance. However, there is a reliable in vivo study available for a structurally similar substance. The substance was found to be negative for chromosomal damage in rat bone marrow in the in vivo cytogenetic test when administered orally by gavage.
Link to relevant study records
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 9 September 1986 - 20 January 1987
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- Read-across
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 475 (Mammalian Bone Marrow Chromosome Aberration Test)
- Version / remarks:
- 1984
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- 1984
- GLP compliance:
- yes
- Type of assay:
- other: Micronucleus assay
- Specific details on test material used for the study:
- Batch number: E06130085
Purity: 50.3% - Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: CRL UK
- Assigned to test groups randomly: yes
- Fasting period before study: overnight prior to dosing
- Housing: plastic disposable cages
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 10 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22°C
- Air changes (per hr): 30
- Photoperiod (hrs dark / hrs light): 12 hours artifical light/day
- Route of administration:
- oral: gavage
- Vehicle:
- Sterile distilled water.
- Details on exposure:
- All animals in all groups were dosed by oral gavage with a standard volume of 20 ml/kg bw except that those receiving cyclophosphamide were dosed by IP injection.
- Duration of treatment / exposure:
- Single administration of dose.
- Frequency of treatment:
- Once.
- Post exposure period:
- 48 hours
- Dose / conc.:
- 600 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- 35/sex/dose
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Cyclophosphamide
40 mg/kg bw/day
Prepared in a solution in sterile 0.9% saline at a concentration of 2.0 mg/ml. - Tissues and cell types examined:
- Both femurs were dissected from the animals and the proximal epiphysis was remoaved and the marrow eluted.
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: A preliminary toxicity test was conducted to evaluate the toxicity of the substance at various doses. The dose selcted for the main test was based on the lowest dose that did not result in any toxicity.
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Conclusions:
- The substance was found to be negative for chromosomal damage in rat bone marrow in the in vivo cytogenetic test when administered orally by gavage.
- Executive summary:
The substance was assessed for its potential to induce chromosomal damage in rats dosed by oral gavage at a dose of 600 mg/kg bw. The animals were observed for 48 hours for any signs of toxicity. Two hours prior to sacrifice the animals each received a dose of colchicine to arrest cells in the metaphase stage of cell division. At the end of the observation period the animals were terminated by cervical dislocation and the bone marrow from the femurs were removed for analysis. The substance was found to be negative for chromosomal damage in rat bone marrow in the in vivo cytogenetic test when administered orally by gavage.
Reference
Sampling time (hrs) | Treatment | Doseage (mg/kg bw) | Incidence of aberrant cells (%) | |
Excluding gap damage | Including gap damage | |||
6 | Vehicle P0151 |
- 600 |
0 0 |
0 0 |
24 | Vehicle P0151 Cyclophosphamide |
- 600 40 |
0 0 5.6 |
0 0 5.6 |
48 | Vehicle P0151 |
- 600 |
0 0 |
0 0 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Justification for classification or non-classification
Based on the findings of three reliable in vitro and one reliable in vivo genotoxicity studies conducted on a structurally similar substance, classification of the substance is not justified.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.